Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Aug 2023
Historique:
received: 30 07 2023
revised: 15 08 2023
accepted: 19 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Amplification of the

Identifiants

pubmed: 37685884
pii: ijms241713077
doi: 10.3390/ijms241713077
pmc: PMC10487649
pii:
doi:

Substances chimiques

Crizotinib 53AH36668S
EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1
Proto-Oncogene Proteins c-met EC 2.7.10.1
Tyrosine Kinase Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Thorac Cancer. 2022 Jun;13(11):1619-1630
pubmed: 35437920
J Clin Oncol. 2019 Apr 10;37(11):855-857
pubmed: 30811294
J Thorac Oncol. 2015 Jun;10(6):e40-3
pubmed: 26001148
Acta Pharm Sin B. 2015 Jan;5(1):34-7
pubmed: 26579422
Clin Lung Cancer. 2023 Jan;24(1):82-88
pubmed: 36333268
Clin Lung Cancer. 2022 May;23(3):e210-e221
pubmed: 34887193
J Clin Oncol. 2018 Nov 1;36(31):3101-3109
pubmed: 30156984
Cancers (Basel). 2022 Apr 26;14(9):
pubmed: 35565287
Curr Protoc Hum Genet. 2008 Apr;Chapter 10:Unit 10.11
pubmed: 18428421
Lung Cancer. 2017 Nov;113:14-17
pubmed: 29110841
Nat Med. 2011 Dec 11;18(1):74-82
pubmed: 22157681
Clin Cancer Res. 2023 Jan 4;29(1):221-232
pubmed: 36269795
Eur J Hum Genet. 2022 Feb;30(2):150-159
pubmed: 33981013
Cancer Discov. 2016 Dec;6(12):1334-1341
pubmed: 27694386
Lung Cancer. 2020 Mar;141:37-43
pubmed: 31945708
Lung Cancer. 2020 Aug;146:165-173
pubmed: 32540560
ESMO Open. 2021 Dec;6(6):100280
pubmed: 34634633
J Clin Oncol. 2016 Mar 10;34(8):794-802
pubmed: 26215952
J Thorac Oncol. 2018 Dec;13(12):1962-1967
pubmed: 30149144
Cell. 1997 Mar 7;88(5):593-602
pubmed: 9054499
Case Rep Oncol. 2021 Mar 18;14(1):477-482
pubmed: 33976623
J Thorac Oncol. 2016 Aug;11(8):1293-1304
pubmed: 27262212
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28890946
J Thorac Oncol. 2015 May;10(5):e23-e25
pubmed: 25902175
Front Oncol. 2021 Oct 01;11:722039
pubmed: 34660287
Pharmacol Res. 2021 May;167:105583
pubmed: 33775864
J Clin Oncol. 2010 Jan 10;28(2):357-60
pubmed: 19949011
Thorac Cancer. 2014 Mar;5(2):126-32
pubmed: 26766989
Nucleic Acids Res. 2020 Jan 8;48(D1):D835-D844
pubmed: 31777943
ESMO Open. 2021 Dec;6(6):100319
pubmed: 34837746
J Transl Med. 2019 Feb 21;17(1):52
pubmed: 30791921
BMC Cancer. 2022 Mar 25;22(1):323
pubmed: 35337281
Cancer Discov. 2021 Apr;11(4):874-899
pubmed: 33811122
Int J Mol Sci. 2020 Apr 19;21(8):
pubmed: 32325863
J Clin Oncol. 2018 Mar 20;36(9):841-849
pubmed: 28841389
Med Oncol. 2021 Oct 19;38(12):143
pubmed: 34665336
Exp Hematol Oncol. 2021 Nov 10;10(1):52
pubmed: 34758872
J Thorac Oncol. 2011 Dec;6(12):2011-7
pubmed: 22052230
J Thorac Oncol. 2016 Jul;11(7):e83-5
pubmed: 26988570
APMIS. 2019 May;127(5):288-302
pubmed: 30803032
Clin Cancer Res. 2018 Jul 1;24(13):3108-3118
pubmed: 29530932
J Thorac Oncol. 2023 Apr;18(4):419-435
pubmed: 36441095
Cancer Sci. 2020 Oct;111(10):3813-3823
pubmed: 32735723
Ther Adv Med Oncol. 2023 Mar 18;15:17588359231161409
pubmed: 36950275
Cancers (Basel). 2023 Jan 18;15(3):
pubmed: 36765572
J Clin Oncol. 2018 Sep 25;:JCO2018793455
pubmed: 30252573
Cancer Discov. 2012 Jun;2(6):495-502
pubmed: 22614325
Lancet Oncol. 2020 Mar;21(3):373-386
pubmed: 32027846
Lung Cancer (Auckl). 2019 Mar 12;10:21-26
pubmed: 30881166
J Clin Oncol. 2019 Apr 10;37(11):876-884
pubmed: 30676858
J Thorac Oncol. 2019 Sep;14(9):1666-1671
pubmed: 31228623
Sci Transl Med. 2021 Sep;13(609):eabb3738
pubmed: 34516823
Ann Oncol. 2020 Apr;31(4):544-546
pubmed: 32122695
Oncology. 2022;100(9):467-474
pubmed: 35679833
Tumori. 2022 Jun;108(3):258-262
pubmed: 33849345
Cancers (Basel). 2021 Oct 07;13(19):
pubmed: 34638507
Cancers (Basel). 2023 May 26;15(11):
pubmed: 37296895
Clin Cancer Res. 2019 Dec 15;25(24):7312-7319
pubmed: 31416808
Cell Rep Med. 2020 Apr 21;1(1):
pubmed: 32483558
Ann Oncol. 2009 Feb;20(2):298-304
pubmed: 18836087
Arch Pathol Lab Med. 2018 Mar;142(3):321-346
pubmed: 29355391
Nature. 1998 Sep 10;395(6698):125-6
pubmed: 9744268
J Thorac Oncol. 2018 Sep;13(9):e169-e172
pubmed: 30166014
Lancet Oncol. 2022 Sep;23(9):1167-1179
pubmed: 35908558
Nat Rev Clin Oncol. 2022 Aug;19(8):499-514
pubmed: 35534623
Thorac Cancer. 2022 Feb;13(3):394-403
pubmed: 34958168
Cancers (Basel). 2019 Jul 01;11(7):
pubmed: 31266248
Clin Case Rep. 2021 Jul 23;9(7):e04487
pubmed: 34322251
Lung Cancer. 2016 Aug;98:59-61
pubmed: 27393507
Lung Cancer. 2018 Oct;124:130-134
pubmed: 30268451
Ann Oncol. 2019 Dec 1;30(12):1985-1991
pubmed: 31584608
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
J Thorac Oncol. 2023 Apr;18(4):463-475
pubmed: 36494075
Ann Oncol. 2017 Oct 1;28(10):2622-2624
pubmed: 28961830
Cancer Cell. 2010 Jan 19;17(1):77-88
pubmed: 20129249
Oncotarget. 2018 May 25;9(40):26195-26208
pubmed: 29899852
Nat Commun. 2023 Feb 27;14(1):1070
pubmed: 36849494
J Thorac Oncol. 2021 Jun;16(6):1017-1029
pubmed: 33676017
BMC Cancer. 2015 Feb 06;15:31
pubmed: 25886066
Int J Mol Sci. 2023 Jun 14;24(12):
pubmed: 37373267
Nature. 1998 Sep 10;395(6698):124-5
pubmed: 9744267
Science. 2007 May 18;316(5827):1039-43
pubmed: 17463250
Int J Mol Sci. 2021 Nov 28;22(23):
pubmed: 34884673
Nat Genet. 2017 Dec;49(12):1693-1704
pubmed: 29106415
Transl Lung Cancer Res. 2020 Jun;9(3):603-616
pubmed: 32676323
Br J Cancer. 2019 Oct;121(9):725-737
pubmed: 31564718
J Thorac Oncol. 2017 Jul;12(7):e85-e88
pubmed: 28274743
Clin Cancer Res. 2017 Aug 15;23(16):4929-4937
pubmed: 28396313
JCO Precis Oncol. 2022 Jul;6:e2200040
pubmed: 35797511
Clin Med Insights Oncol. 2022 Nov 11;16:11795549221134735
pubmed: 36387609
Onco Targets Ther. 2017 Sep 13;10:4535-4541
pubmed: 28979145
Future Oncol. 2022 Mar;18(9):1039-1054
pubmed: 34918545
ESMO Open. 2022 Feb;7(1):100347
pubmed: 34953403
Clin Cancer Res. 2015 Feb 15;21(4):907-15
pubmed: 25492085
Mol Cancer Ther. 2023 Jul 5;22(7):833-843
pubmed: 36999986
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221128414
pubmed: 36148917
J Thorac Oncol. 2018 Apr;13(4):e49-e53
pubmed: 29128427
J Cancer Res Clin Oncol. 2021 Dec;147(12):3653-3664
pubmed: 34661758
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2026-30
pubmed: 8134344
Cancer Discov. 2023 Jan 9;13(1):98-113
pubmed: 36264123
J Cancer Res Clin Oncol. 2023 May;149(5):1667-1677
pubmed: 35583827

Auteurs

Edyta M Urbanska (EM)

Department of Oncology, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.

Morten Grauslund (M)

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.

Peter R Koffeldt (PR)

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.

Sarah L B Truelsen (SLB)

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.

Johan O Löfgren (JO)

Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.

Junia C Costa (JC)

Department of Radiology, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.

Linea C Melchior (LC)

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.

Jens B Sørensen (JB)

Department of Oncology, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, DK-2200 Copenhagen, Denmark.

Eric Santoni-Rugiu (E)

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, DK-2200 Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH